DETERMINANTS FOR CLINICAL ACTIVITY OF NEUROLEPTICS - PATIENTS, CLINICAL SUBSTANCES, DOSES

被引:0
|
作者
BOYER, P
PUECH, AJ
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [1] PROBLEM OF CLINICAL ACTIVITY OF LONG-ACTING NEUROLEPTICS
    SMULEVITCH, AB
    MINSKER, EI
    MAZAYEVA, NA
    VOLKOVA, RP
    LUKANINA, SK
    COMPREHENSIVE PSYCHIATRY, 1973, 14 (03) : 227 - 233
  • [2] CLINICAL EFFECTS OF NEUROLEPTICS
    VOVIN, RY
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1984, 84 (03): : 413 - 418
  • [3] COMPARISON OF STANDARD AND HIGH-DOSES OF NEUROLEPTICS - STUDY OF CLINICAL, PHARMACOKINETIC AND PHARMACODYNAMIC VARIABLES
    SCHILKRUT, R
    HAVERBECK, C
    DURAN, E
    DELGADO, S
    KOHEN, P
    BIRKNER, R
    KATZ, I
    ACTA PSIQUIATRICA Y PSICOLOGICA DE AMERICA LATINA, 1981, 27 (4-5) : 315 - 324
  • [4] CLINICAL EXPERIENCE WITH DEPOT NEUROLEPTICS
    BAKKE, O
    ACTA PSYCHIATRICA SCANDINAVICA, 1973, : 33 - 41
  • [5] STEREOSPECIFICITY AND CLINICAL POTENCY OF NEUROLEPTICS
    CROW, TJ
    DEAKIN, JWF
    JOHNSTONE, EC
    NATURE, 1977, 267 (5607) : 183 - 184
  • [6] Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
    Cobo, Gabriela
    Gallar, Paloma
    Gama-Axelsson, Thiane
    Di Gioia, Cristina
    Qureshi, Abdul Rashid
    Camacho, Rosa
    Vigil, Ana
    Heimburger, Olof
    Ortega, Olimpia
    Rodriguez, Isabel
    Carlos Herrero, Juan
    Barany, Peter
    Lindholm, Bengt
    Stenvinkel, Peter
    Carrero, Juan Jesus
    JOURNAL OF NEPHROLOGY, 2015, 28 (04) : 503 - 510
  • [7] Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
    Gabriela Cobo
    Paloma Gallar
    Thiane Gama-Axelsson
    Cristina Di Gioia
    Abdul Rashid Qureshi
    Rosa Camacho
    Ana Vigil
    Olof Heimbürger
    Olimpia Ortega
    Isabel Rodriguez
    Juan Carlos Herrero
    Peter Bárány
    Bengt Lindholm
    Peter Stenvinkel
    Juan Jesús Carrero
    Journal of Nephrology, 2015, 28 : 503 - 510
  • [8] STUDY OF THE CLINICAL UTILITY OF RADIORECEPTOR ASSAY IN OUTPATIENTS WITH SCHIZOPHRENIA RECEIVING HIGH-DOSES OF NEUROLEPTICS
    GAGNE, MA
    CORMIER, H
    LEBLANC, G
    LEVESQUE, D
    DIPAOLO, T
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1993, 38 (08): : 534 - 540
  • [9] Nutritional, biochemical, and clinical determinants of hyperuricemia in systemic lupus erythematosus patients: Relationship with clinical and renal disease activity
    Campos-Lopez, Bertha
    Meza-Meza, Monica R.
    Pesqueda-Cendejas, Karen
    Ruiz-Ballesteros, Adolfo, I
    Rivera-Escoto, Melissa
    Vargas-Morales, Juan M.
    Parra-Rojas, Isela
    Mora-Garcia, Paulina E.
    Vizmanos, Barbara
    Montoya-Buelna, Margarita
    Cerpa-Cruz, Sergio
    De la Cruz-Mosso, Ulises
    LUPUS, 2023, 32 (02) : 270 - 283
  • [10] CLINICAL-CRITERIA OF CHOICE FOR NEUROLEPTICS
    HOES, MJAJM
    TGO-TIJDSCHRIFT VOOR GENEESMIDDELENONDERZOEK-JOURNAL OF DRUG RESEARCH-JDR, 1983, 8 (08): : 1976 - 1983